Skip to main content
European Commission logo print header

Psychiatric Disorders: ATX-inhibiting drugs as a new therapeutic option: Proof-of-Concept

Publications

Correction: Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders

Author(s): Carine Thalman, Guilherme Horta, Lianyong Qiao, Heiko Endle, Irmgard Tegeder, Hong Cheng, Gregor Laube, Torfi Sigurdsson, Maria Jelena Hauser, Stefan Tenzer, Ute Distler, Junken Aoki, Andrew J. Morris, Gerd Geisslinger, Jochen Röper, Sergei Kirischuk, Heiko J. Luhmann, Konstantin Radyushkin, Robert Nitsch, Johannes Vogt
Published in: Molecular Psychiatry, Issue 25/11, 2020, Page(s) 3108-3108, ISSN 1359-4184
Publisher: Nature Publishing Group
DOI: 10.1038/s41380-018-0320-1

Intellectual Property Rights

LPA LEVEL REDUCTION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

Application/Publication number: 16 787728
Date: 2016-10-21
Applicant(s): UNIVERSITAET MUENSTER

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available